unknown
Stage
2020
Founded
2
Investors
About
Epigenic Therapeutics develops epigenetic gene-modulation therapies using its proprietary EPIREG platform, which applies AI-optimized CRISPR-based components to regulate target gene expression without changing DNA sequence for treatment of human diseases.
Explore Epigenic Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.